Latest News
Rezolute, Inc.
- Rezolute, Inc. Estimates – FWB:6HV1
- Rezolute stock holds Buy rating at H.C. Wainwright on trial progress
- Citizens reiterates Market Outperform on Rezolute stock on trial data
- Rezolute completes enrollment in Phase 3 upLIFT; topline results expected mid-December 2026
- Rezolute (RZLT) Completes Enrollment in Phase 3 Trial for Ersode
- Rezolute Announces Completion Of Enrollment In Phase 3 Uplift Study Of Ersodetug In Tumor Hyperinsulinism
- H.C. Wainwright reiterates Buy on Rezolute stock, $10 target
- Rezolute upgraded at Cantor on pre-BLA meeting for ersodetug
- Rezolute Gets FDA Nod For Pre-BLA Meeting Despite Phase 3 Miss — Retail Expects ‘Huge Rerating’
- FDA Recommends Meeting for Rezolute Drug for Rare Blood Sugar Disorder Despite Missed Endpoints
- Rezolute stock rating upgraded to Buy at Craig-Hallum on trial data
- Rezolute Inc (NASDAQ: RZLT) Share Price, RZLT Stock News, RZLT Share Price & Updates
Headlines from the last 30 days, linking to the original publishers. See all market news →